“Limiting State Flexibility in Drug Pricing”

  • Health Law
New England Journal of Medicine
2018

“Scientific Trials-In the Laboratories, Not the Courts”

  • Litigation
  • Health Law
JAMA Internal Medicine
2018

“Innovative Contracting for Pharmaceuticals and Medicaid’s Best-Price Rule”

  • Public Interest Law
  • Health Law
Journal of Health Politics, Policy and Law
2018

Health Care Law and Ethics

  • Legal Ethics and Professional Responsibility
  • Health Law
2018

Marijuana Law in a Nutshell

  • Criminal Law
  • Health Law
2017

“Insurance for broad genomic tests in oncology”

  • Health Law
Science
2017

“Risk and Resilience in Health Data Infrastructure”

  • Law and Technology
  • Health Law
Colorado Technology Law Journal
2017

“Regulating Black-Box Medicine”

  • Law and Technology
  • Health Law
Michigan Law Review
2017

“Artificial Intelligence in Health Care: Applications and Legal Issues”

  • Law and Technology
  • Health Law
The SciTech. Lawyer
2017

“Disability, Universalism, Social Rights, and Citizenship”

  • Civil Rights
  • Health Law
Cardozo Law Review
2017

“Expired Patents, Trade Secrets, and Stymied Competition”

  • Law and Technology
  • Health Law
Notre Dame Law Review
2017

“An Empirical Window into Retrospective Review”

  • Corporate and Securities Law
  • Administrative Law
  • Health Law
Jotwell: The Journal of Things We Like (Lots)
2017

“Small Change, Big Consequences — Partial Medicaid Expansions under the ACA”

  • Health Law
New England Journal of Medicine
2017

“Federalism and the End of Obamacare”

  • Health Law
Yale Law Journal Forum
2017

“The Dubious Empirical and Legal Foundations of Wellness Programs”

  • Health Law
  • Labor and Employment Law
Health Matrix: Journal of Law-Medicine
2017

“Privacy and Accountability in Black-Box Medicine”

  • Law and Technology
  • Health Law
Michigan Telecommunications and Technology Law Review
2016

“Big Data, Patents, and the Future of Medicine”

  • Law and Technology
  • Health Law
Cardozo Law Review
2016

“Making Elder Financial Exploitation Cases Part of a Sustainable Practice: Tips from the Experiences of the University of Illinois College of Law’s Elder Financial Justice Clinic”

  • Criminal Law
  • Health Law
Elder Law Journal
2016

“Regulating Secrecy”

  • Law and Technology
  • Health Law
Washington Law Review
2016

“Codon Influence on Large-Scale Protein Expression Correlates with E. coli mRNA Levels”

  • Law and Technology
  • Health Law
Nature
2016

“The Need for a Privacy Standard for Medical Devices That Transmit Protected Health Information Used in the Precision Medicine Initiative for Diabetes and Other Diseases”

  • Law and Technology
  • Health Law
Journal of Diabetes Science and Technology
2016

“Manufacturing Barriers to Biologics Competition and Innovation”

  • Law and Technology
  • Health Law
Iowa Law Review
2016

“From Integrationism to Equal Protection: tenBroek and the Next 25 Years of Disability Rights”

  • Civil Rights
  • Health Law
University of St Thomas Law Journal
2016

“Legal Limits and the Implementation of the Affordable Care Act”

  • Health Law
University of Pennsylvania Law Review
2016

“A Legal Setback for the Affordable Care Act”

  • Health Law
New England Journal of Medicine
2016

“Trouble on the Exchanges — Does the United States Owe Billions to Health Insurers?”

  • Health Law
New England Journal of Medicine
2016

“The Disability Cliff”

  • Civil Rights
  • Health Law
Democracy
2015

“Black-Box Medicine”

  • Law and Technology
  • Health Law
Harvard Journal of Law & Technology
2015

“Innovation Policy Failures in the Manufacturing of Drugs”

  • Law and Technology
  • Health Law
FDA in the Twenty-First Century: The Challenges of Regulating Drugs and New Technologies
2015

“Introduction to ‘Timing is Everything: Balancing Access and Uncertainty’ ”

  • Law and Technology
  • Health Law
FDA in the Twenty-First Century: The Challenges of Regulating Drugs and New Technologies
2015

“Are Trade Secrets Delaying Biosimilars?”

  • Law and Technology
  • Health Law
Science
2015

“Will Clinical Trial Data Disclosure Reduce Incentives to Develop New Uses of Drugs?”

  • Law and Technology
  • Health Law
Nature Biotechnology
2015

“Is the Chief Justice a Tax Lawyer?”

  • Administrative Law
  • Health Law
Pepperdine Law Review
2015

“Describing Black-Box Medicine”

  • Law and Technology
  • Health Law
Boston University Journal of Science & Technology Law
2015

“The ADA and the Supreme Court: A Mixed Record”

  • Civil Rights
  • Health Law
Journal of the American Medical Association
2015

“Protection or Harm? Suppressing Substance-Use Data”

  • Health Law
New England Journal of Medicine
2015

“No Good Options: Picking Up the Pieces After King v. Burwell”

  • Health Law
Yale Law Journal Forum
2015

“Medicine as a Public Calling”

  • Health Law
Michigan Law Review
2015

“Essential Health Benefits and the Affordable Care Act”

  • Health Law
The Future of Healthcare Reform in the United States
2015

“Predicting the Fallout from King v. Burwell - Exchanges and the ACA”

  • Health Law
New England Journal of Medicine
2015

“Three Words and the Future of the Affordable Care Act”

  • Health Law
Journal of Health Politics, Policy and Law
2015

“Transparency and the Supreme Court—Can Employers Refuse to Disclose How Much They Pay for Health Care?”

  • Health Law
  • Labor and Employment Law
New England Journal of Medicine
2015

“Generic Entry Jujitsu: Innovation and Quality in Drug Manufacturing”

  • Law and Technology
  • Health Law
IP Theory
2014

“Nudging the FDA”

  • Law and Technology
  • Health Law
The American Interest
2014

“Environmental Law, Public Health, and the Values Conundrum”

  • Criminal Law
  • Environmental and Energy Law
  • Public Interest Law
  • Health Law
Michigan Journal of Environmental and Administrative Law
2014

“The Ordinary Remand Rule and the Judicial Toolbox for Agency Dialogue”

  • Constitutional Law
  • Health Law
George Washington Law Review
2014

“Making Do in Making Drugs: Innovation Policy and Pharmaceutical Manufacturing”

  • Law and Technology
  • Health Law
Boston College Law Review
2014

“Patent Trolling - Why Bio & Pharmaceuticals Are at Risk”

  • Law and Technology
  • Health Law
Stanford Technology Law Review
2014

“Models of Consent to Return of Incidental Findings in Genomic Research”

  • Law and Technology
  • Health Law
Hastings Center Report
2014

“The Legality of Delaying Key Elements of the ACA”

  • Health Law
New England Journal of Medicine
2014